1. Introduction

Data fiduciary obligations in neurotechnology concern the legal duties of organisations that collect, analyse, store, disclose, or otherwise process data generated by the human brain and nervous system. These organisations may include brain-computer interface (BCI) manufacturers, neurotechnology startups, hospitals, neuroscience research institutions, wearable EEG developers, and companies offering neural-data analytics.

Neurotechnology creates distinctive privacy risks because neural signals can reveal, or be used to infer, information about a person's attention, emotional responses, cognitive performance, neurological condition, and other aspects of mental activity. The legal concern is not limited to the raw brain signal: derived profiles, predictions, and behavioural classifications may also create serious risks.

The central legal question is:

When an organisation obtains access to a person's neural data, what duties does it owe that person, and what remedies are available if those duties are breached?

The answer depends on the jurisdiction, the purpose of processing, the technology used, and whether the information qualifies as personal, health, biometric, or another specially protected category of data. The European Parliament's research on mental privacy and the UK's Information Commissioner's Office both identify important classification challenges for neural data.

European Parliament+1

2. Meaning and scope of data fiduciary obligations

A data fiduciary is an entity that determines why and how personal data is processed, subject to the definition in the applicable law. Under India's Digital Personal Data Protection Act, 2023 (DPDP Act), the term has a specific statutory meaning.

In neurotechnology, potential fiduciaries include:

A BCI company collecting neural signals through a headset.

A hospital using neural recordings for diagnosis or treatment.

A research institution analysing EEG data.

A software provider inferring mental states from brain activity.

A cloud platform determining how neural datasets are processed and reused.

A technology provider is not automatically the fiduciary for every processing operation. A hospital or research institution may determine the purposes, while a cloud provider may act as a processor. The actual contractual and operational arrangement matters.

Types of neurodata

EEG Test in Pune | Dr. Chetna Patil - ,Pune.

Raw neural data

Electrical brain signals, EEG recordings, neural firing measurements, and signals from implanted electrodes. These may identify a person or reveal health-related information, depending on context.

Are Brain-Computer-Interfaces Ethical? | by Liam Zachary Edwards | Medium

Processed neural data

Digitally filtered signals, neural features, and measurements extracted from brain activity for analysis or device control.

EEG Signal Processing Pipeline for Enhanced Model Performance | Cerebralink Neurotech Consultancy

Inferred mental or behavioural data

Predictions about attention, fatigue, emotional responses, cognitive performance, or possible health conditions. Such inferences can be sensitive even when they are uncertain or inaccurate.

A crucial legal distinction is that not every neural signal automatically receives the same special-category protection. Its relationship to an identifiable individual, its intended use, and what can reasonably be inferred from it may determine the applicable legal safeguards.

ICO+1

3. Principal duties of a neurotechnology data fiduciary

A. Lawful processing and informed consent

A neurotechnology provider must identify a valid legal basis for processing personal data. Where consent is relied upon, the user should understand what data is collected, why it is collected, how it will be used, and whether it will be shared.

For example, a person consenting to use a BCI to control a cursor has not necessarily agreed to the commercial analysis of their neural responses for advertising or employee-performance scoring.

Good practice includes:

Separating consent for treatment, device operation, research, and commercial reuse.

Explaining material risks and limitations in accessible language.

Making optional processing genuinely optional.

Providing a practical way to withdraw consent where consent is the legal basis.

Avoiding consent designs that pressure patients, employees, or research participants into accepting unrelated uses.

Consent to data processing is also distinct from informed consent to a medical procedure or participation in research. Each may require its own legal analysis.

B. Purpose limitation and data minimisation

Data should be collected and used only for justified purposes and to the extent permitted by applicable law.

A company operating an EEG-based meditation device, for example, should not automatically repurpose recordings for emotion prediction, insurance risk assessments, or targeted advertising merely because the technical infrastructure makes those uses possible.

The fiduciary should document:

The original purpose of collection.

Which data fields are necessary for that purpose.

Whether a proposed secondary use is legally permissible.

Whether the secondary use requires a new legal basis or consent.

When data must be deleted or irreversibly anonymised, where legally appropriate.

C. Confidentiality and security

Neural datasets may be valuable targets for cyberattacks, commercial exploitation, and unauthorised disclosure. Appropriate safeguards may include encryption, access restrictions, separation of identifiers from neural recordings, audit logs, secure model-development environments, and controls on third-party access.

A breach involving raw neural recordings may create different risks from a breach involving ordinary contact information. However, the severity depends on the data's sensitivity, identifiability, and potential uses.

D. Transparency and explainability

People should receive understandable information about consequential processing of their neural data.

Where a system infers fatigue, attention, or emotional states, the provider should avoid presenting uncertain predictions as established facts. Where those predictions influence employment, healthcare, education, or access to services, stronger review and accountability measures may be necessary under applicable law.

E. Data accuracy and correction

Neural inference systems can generate false positives and biased conclusions. A fiduciary should take appropriate steps to address inaccurate data, especially when it may influence decisions affecting an individual.

For instance, an EEG-based workplace system might incorrectly classify a worker as inattentive because of movement, device fit, signal noise, or individual neurological variation. The organisation should not treat the resulting score as conclusive evidence of poor performance.

F. Retention, deletion, and withdrawal

Organisations should establish retention schedules and secure deletion procedures. Withdrawal of consent does not necessarily erase records that must lawfully be retained for clinical, regulatory, research-integrity, or legal purposes, but those exceptions must be assessed under the applicable rules.

G. Accountability for processors and partners

A fiduciary cannot assume that outsourcing neural-data processing automatically transfers all its legal responsibilities.

Contracts with cloud providers, analytics vendors, and research partners should address permitted purposes, security, confidentiality, onward transfers, incident notification, deletion, audit rights, and assistance with individual requests.

These duties become especially important when the organisation supplying a BCI also controls the associated cloud account, proprietary analytics software, or model-training pipeline.

4. Leading case laws

The most important decisions for this subject include a direct neurotechnology judgment from Chile and broader privacy judgments from India and Europe. The distinction is important: some cases directly concern neural data, while others establish legal principles that can be applied to neurotechnology.

Case 1: Girardi v. Emotiv Inc. — Chilean Supreme Court (2023)

Case No. Rol 105.065-2023 · Judgment dated 9 August 2023

Facts: Guido Girardi used Emotiv's Insight EEG headset, which records electrical brain activity. He challenged the company's collection and retention of his brain data, raising concerns about privacy, security, unauthorised reuse, and continued retention after account closure.

Legal issues:

Whether neural recordings deserve protection as personal information.

Whether storing neural data creates risks to mental privacy and psychological integrity.

Whether the company's practices and the device's commercialisation complied with Chilean law.

Decision: The Supreme Court of Chile allowed the constitutional protection action. It ordered the relevant health and customs authorities to evaluate the device and its data handling under the applicable law. The case is also reported as directing deletion of the user's stored brain data.

derechocienciaytecnologia.uc.cl+1

Legal significance: The decision is a leading direct judicial example of legal protection for neural information. It demonstrates that ordinary data-processing practices may raise constitutional concerns when the information concerns brain activity.

Application to fiduciary duties: A neurotechnology company should establish a defensible legal basis for collection and retention, provide meaningful transparency, secure neural data, respect applicable cancellation rights, and assess regulatory requirements before marketing its device.

Important qualification: The judgment should not be interpreted as establishing a universal rule that every EEG device requires medical-device authorisation or that all neural data must always be deleted. Those questions depend on the device, its intended purpose, applicable law, and the specific order.

Case 2: Justice K.S. Puttaswamy (Retd.) v. Union of India — Supreme Court of India (2017)

Citation: (2017) 10 SCC 1 · Nine-judge Constitution Bench

Facts: The case concerned whether privacy is a fundamental right under the Indian Constitution.

Decision: The Supreme Court unanimously recognised privacy as a constitutionally protected right, including informational privacy, grounded in liberty, dignity, and personal autonomy. The judgment also explained that restrictions on privacy must satisfy requirements including legality, legitimate state purpose, and proportionality.

Indian Kanoon+1

Application to neurotechnology: Although the case did not concern a brain-computer interface, its principles are highly relevant to neural-data collection by public and private entities.

For example, compulsory workplace brain monitoring could raise questions about:

Personal autonomy and mental privacy.

Whether the interference has a lawful basis.

Whether the monitoring is necessary and proportionate.

Whether less intrusive alternatives are available.

Legal significance: Puttaswamy supplies a constitutional foundation for challenging disproportionate or unlawful neural surveillance in India. It does not, by itself, establish a separate constitutional right expressly named the “right to neural privacy.”

Case 3: K.S. Puttaswamy v. Union of India — proportionality and informational privacy

The broader principles articulated in the privacy judgment are particularly relevant when the government proposes to use neurotechnology for security, law enforcement, education, or public administration.

The constitutional analysis asks whether there is a valid law, a legitimate objective, and a proportionate means of achieving that objective.

Indian Kanoon+1

Hypothetical application: If a public authority required individuals to submit brain-signal data to predict future misconduct, a court could examine the legality of the programme, the scientific reliability of its predictions, the seriousness of the intrusion, safeguards against misuse, and whether a less invasive method could achieve the same objective.

This is an application of existing constitutional principles, not a reported holding specifically about predictive neural surveillance.

Case 4: Selvi v. State of Karnataka — Supreme Court of India (2010)

Citation: (2010) 7 SCC 263

Facts: The case concerned the involuntary administration of narcoanalysis, polygraph examinations, and brain electrical activation profile (BEAP) tests in criminal investigations.

Decision: The Supreme Court held that the involuntary administration of these techniques violated constitutional protections, including the right against self-incrimination under Article 20(3) and personal liberty under Article 21, in the circumstances examined by the Court.

Application to neurotechnology: The judgment is especially relevant to attempts to obtain brain-derived evidence without valid consent. It supports the principle that the state cannot simply treat brain-based testing as an ordinary investigative tool free from constitutional constraints.

Limit: Selvi concerns specific investigative techniques and involuntary testing. It does not categorically prohibit every consensual EEG examination, clinical BCI, or voluntary neuroscience study.

Case 5: Bărbulescu v. Romania — European Court of Human Rights (2017)

Application No. 61496/08 · Grand Chamber judgment

Facts: An employee's electronic communications were monitored by his employer, raising questions about workplace privacy.

Decision: The European Court of Human Rights examined whether adequate safeguards had been provided to protect the employee's private life and correspondence under Article 8 of the European Convention on Human Rights.

Application to neurotechnology: If an employer monitors an employee's brain activity to measure attention, fatigue, or productivity, similar questions may arise concerning prior notice, the extent and duration of monitoring, access to results, legitimate purpose, and safeguards against excessive surveillance.

Legal significance: This is an analogy from electronic communications monitoring, not a ruling on neural data. It illustrates why workplace monitoring must be assessed in context rather than justified solely by an employer's ownership of the equipment.

Case 6: López Ribalda and Others v. Spain — European Court of Human Rights (2019)

Facts: The case involved covert video surveillance of employees in a supermarket following suspected theft.

Decision: The Grand Chamber assessed the proportionality of the surveillance under Article 8, considering the circumstances and safeguards.

Application to neurotechnology: An employer's covert collection of neural data would raise serious questions about intrusiveness, necessity, duration, and access to the resulting information. Because brain data can reveal intimate information, the privacy impact could be substantial.

Limit: The case concerned video surveillance, not brain monitoring. Its relevance is by analogy and does not establish a specific legal test for every neural-data system.

The last two cases demonstrate how established privacy principles can inform neurotechnology governance even before courts develop a substantial body of neurotechnology-specific precedent.

5. Indian statutory framework: DPDP Act, 2023

India does not yet have a separate comprehensive statute devoted exclusively to neural data. The DPDP Act, 2023 provides a general framework for digital personal data, while constitutional privacy, information-technology rules, medical regulation, and research-ethics requirements may also be relevant.

A significant implementation detail is that the DPDP Act has a phased commencement schedule. Although the DPDP Rules, 2025 were notified in November 2025, the Gazette commencement notification schedules the substantive provisions in Sections 3–17, including Sections 4–10 on processing and fiduciary duties, for commencement 18 months after publication in November 2025—May 2027. Therefore, as of 4 November 2026, those substantive provisions should not be described as already operative.

Press Information Bureau+2

Key statutory provisions

These are the Act's enacted provisions, but their scheduled commencement must be distinguished from their future substantive effect.

Indian Kanoon+2

A. Section 6: Consent and neural data

Once applicable, Section 6 is particularly relevant when a BCI company relies on consent to process neural data. Consent must be free, specific, informed, unconditional, and unambiguous, expressed through clear affirmative action.

A broad statement such as “I agree to all data uses” may not adequately explain the difference between operating a medical device and using the resulting recordings for unrelated commercial analytics.

The organisation should separately evaluate research, product improvement, model training, disclosure to third parties, and other secondary purposes.

B. Section 8: General obligations

Section 8 is central to fiduciary accountability. Among other things, it places responsibility on the fiduciary for processing carried out on its behalf by a processor under the Act.

For a neurotechnology provider, this means that outsourcing storage or analysis does not, by itself, eliminate responsibility for the provider's own compliance obligations. Security safeguards, breach procedures, retention rules, and grievance mechanisms are all relevant.

C. Section 9: Children

Neurotechnology systems used in schools, paediatric treatment, or child-focused consumer products require special attention. Section 9 provides for verifiable parental consent, restrictions on detrimental processing, and restrictions on tracking or behavioural monitoring of children, subject to the Act's exceptions.

D. Section 10: Significant Data Fiduciaries

The Central Government may designate entities as Significant Data Fiduciaries based on relevant factors, including the volume and sensitivity of personal data and risks to individuals.

If a neurotechnology company receives such a designation, the additional requirements can include a designated Data Protection Officer, an independent data auditor, and periodic data-protection impact assessments and audits.

These provisions offer a framework for high-risk neural-data processing, but designation is not automatic merely because a company handles brain data.

Indian Kanoon+1

E. What applies in India before May 2027?

The commencement schedule is important for determining enforceable statutory duties. During the transition, applicable existing law must be examined separately, including the Information Technology Act, 2000, the Information Technology (Reasonable Security Practices and Procedures and Sensitive Personal Data or Information) Rules, 2011, constitutional privacy principles, and relevant healthcare or research rules.

The precise application of each instrument depends on the organisation, data, activity, and applicable exemptions. The future DPDP obligations should not be used as if every substantive provision were already in force.

6. Comparative international legal frameworks

European Union — GDPR

The General Data Protection Regulation may apply to neural data when it constitutes personal data. If the data reveals a person's physical or mental health, the special-category rules in Article 9 may apply, alongside a lawful basis under Article 6.

Key duties include purpose limitation, data minimisation, transparency, security, data-subject rights, and accountability. High-risk processing may require a data-protection impact assessment under Article 35.

Important distinction: Neural data is not automatically special-category data in every context. The nature of the information and what it reveals matter.

European Parliament+1

United Kingdom — UK GDPR and Data Protection Act 2018

Identifiable neural data can constitute personal data. Neural recordings processed for medical purposes are likely to qualify as health data in relevant circumstances, triggering special-category safeguards.

The Information Commissioner's Office identifies unresolved questions about how neurodata and inferred mental states should be classified, particularly in consumer enhancement products.

ICO

Chile — constitutional neurorights

Chile has constitutional provisions addressing brain activity and neurotechnology. The Girardi v. Emotiv judgment demonstrates the practical use of constitutional protection and existing personal-data law in a dispute involving neural recordings.

This is an especially relevant jurisdiction for examining mental privacy and neural-data retention.

derechocienciaytecnologia.uc.cl+1

United States — sectoral and consumer protection

The United States does not have one comprehensive federal privacy statute covering all consumer neural data. Depending on the activity, relevant protections may arise from the Federal Trade Commission Act, health-privacy legislation, state consumer privacy laws, and specific biometric or health-data statutes.

Whether HIPAA applies depends on the covered entity, business-associate relationship, and information involved. A consumer EEG application is not automatically subject to HIPAA merely because it collects health-related information.

7. UNESCO's Recommendation on the Ethics of Neurotechnology

In November 2025, UNESCO adopted the Recommendation on the Ethics of Neurotechnology, establishing an international normative framework addressing the ethical and human-rights implications of neurotechnology. It addresses neural data, indirect neural data, and other information that can enable inferences about mental states.

UNESCO+2

Its relevance to fiduciary obligations includes:

Respect for human dignity, autonomy, and mental privacy.

Protection of neural information against misuse and exploitation.

Responsible development and deployment of neurotechnology.

Attention to uses beyond medicine, including employment, education, and commercial services.

Appropriate governance throughout the technology lifecycle.

The Recommendation is not itself a binding treaty or a directly enforceable data-protection statute. Its principles can guide national legislation, regulatory policy, institutional ethics, and organisational governance.

8. Practical application: a neurotechnology compliance example

Consider a company selling an EEG headset that measures attention during work and uploads recordings to a cloud service.

Illustrative compliance assessment

The following is a practical application of the legal principles, not a finding in a reported case.

Collection: Explain what the headset records and whether raw neural signals are transmitted off the device.

Purpose: Distinguish the functions needed to operate the device from workplace scoring, research, and commercial profiling.

Consent and legal basis: Determine the applicable legal basis and whether consent is genuinely voluntary in the employment context.

Security: Encrypt recordings, restrict access, assess cloud providers, and maintain incident-response procedures.

Decision safeguards: Do not treat an uncertain attention score as definitive proof of misconduct or lack of competence.

Retention: Establish deletion periods and address withdrawal requests, legal retention requirements, and processor-held copies.

Remedies: Provide an accessible complaint channel and a mechanism for correcting inaccurate information or challenging consequential decisions.

The strongest governance approach combines legal compliance with a documented assessment of the scientific limitations of the technology. Even where collection is lawful, an inference may be unreliable, discriminatory, or disproportionate for the decision in which it is used.

9. Legal remedies for breach of fiduciary obligations

Depending on the jurisdiction and the facts, an affected person may be able to seek:

Data-protection remedies: Access, correction, erasure, restriction, or withdrawal of consent where provided by applicable law.

Regulatory intervention: Investigation, corrective directions, penalties, or other statutory measures.

Constitutional relief: A claim involving privacy, dignity, liberty, or mental integrity where constitutional requirements are met.

Civil remedies: Damages or other relief where a recognised cause of action and its legal requirements are established.

Employment or healthcare remedies: Challenges to unlawful monitoring, unfair decision-making, improper disclosure, or violations of professional obligations.

In Girardi v. Emotiv, the Chilean Supreme Court's order illustrates how a neural-data dispute can lead to both individual relief and regulatory scrutiny. In India, Puttaswamy and Selvi provide important constitutional foundations, although the available remedy will depend on the particular violation and procedural route.

A breach does not automatically entitle every claimant to compensation. The applicable statute, evidence, causation, standing, and requirements for relief must be examined.

10. Unresolved legal issues

Several questions remain unsettled across jurisdictions.

First, inferred mental states. If a company deletes raw EEG signals but retains a profile predicting a person's emotional state, does the profile remain protected personal data? Often it may, depending on identifiability and applicable definitions, but the answer is not uniform.

Second, anonymisation. Neural datasets can present re-identification risks. A company should not assume that removing names alone makes a dataset legally anonymous.

Third, consent under unequal power relationships. Patients may depend on a hospital for treatment, and employees may fear refusing workplace monitoring. Formal consent does not necessarily resolve every question about voluntariness, proportionality, or fairness.

Fourth, ownership and control. Possessing a device, owning its software, or holding intellectual-property rights in an algorithm does not automatically establish unrestricted rights to exploit the individual's neural data.

Fifth, cross-border processing. Neural data transferred between hospitals, cloud providers, and international research collaborators may be subject to different legal regimes and transfer restrictions.

Sixth, scientific reliability. Fiduciary compliance should not be confused with scientific validity. A system may comply with basic data-security requirements yet still generate misleading predictions that harm individuals.

11. Conclusion

Data fiduciary obligations in neurotechnology are an emerging intersection of data protection, constitutional privacy, medical law, consumer protection, and neuroethics.

The Chilean Supreme Court's Girardi v. Emotiv Inc. decision is a particularly significant direct precedent concerning brain data. India's Puttaswamy and Selvi judgments supply complementary principles concerning informational privacy, autonomy, mental integrity, and involuntary brain-based testing.

For organisations developing or deploying neurotechnology, the principal legal priorities are lawful processing, meaningful transparency, purpose limitation, appropriate security, responsible retention, accountability for processors, and safeguards against harmful or unreliable inferences.

The ultimate legal challenge is to protect not only the confidentiality of neural recordings but also the individual's ability to preserve autonomy and dignity when information about brain activity is collected, interpreted, and used by others.

Legal research note: This is a comparative educational overview, not jurisdiction-specific legal advice. For a concrete dispute, verify the current statutory commencement dates, the precise judgment text, and the law governing the relevant organisation and data-processing activity.